Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry A Rosenzweig

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
BMC Biotechnology|April 14, 2011
An adaptable method using human mixed tissue ratiometric controls for benchmarking performance on gene expression microarrays in clinical laboratoriesP Scott Pine, Barry A Rosenzweig, Karol L Thompson
Comparative Medicine|September 14, 2018
Outbreak of Opportunistic Ascending Pyelonephritis with Numerous Yeast after Experimental Humanization Surgery in NOD.Cg-Leah M Zadrozny, Lauren R Brinster, Barry A Rosenzweig, et al.
BMC Biotechnology|September 15, 2007
Characterization of the effect of sample quality on high density oligonucleotide microarray data using progressively degraded rat liver RNAKarol L Thompson, P Scott Pine, Barry A Rosenzweig, et al.
Kidney International|December 15, 2010
Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in ratsRodney L Rouse, Jun Zhang, Sharron R Stewart, et al.
Toxicology Letters|July 26, 2012
Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in ratsKarol L Thompson, Jun Zhang, Sharron Stewart, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 30, 2003
Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent componentsKarol L Thompson, Barry A Rosenzweig, James L Weaver, et al.
Disease Markers|April 26, 2016
The Effect of Oseltamivir on the Disease Progression of Lethal Influenza A Virus Infection: Plasma Cytokine and miRNA Responses in a Mouse ModelAshok K Chockalingam, Salaheldin Hamed, David G Goodwin, et al.
Environmental Health Perspectives|March 23, 2004
Dye bias correction in dual-labeled cDNA microarray gene expression measurementsBarry A Rosenzweig, P Scott Pine, Olen E Domon, et al.
International Journal of Toxicology|January 24, 2012
Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the ratKarol L Thompson, Kylie Haskins, Barry A Rosenzweig, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2009
Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in ratsKarol L Thompson, Barry A Rosenzweig, Jun Zhang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMC Biotechnology|April 14, 2011
An adaptable method using human mixed tissue ratiometric controls for benchmarking performance on gene expression microarrays in clinical laboratoriesP Scott Pine, Barry A Rosenzweig, Karol L Thompson
Comparative Medicine|September 14, 2018
Outbreak of Opportunistic Ascending Pyelonephritis with Numerous Yeast after Experimental Humanization Surgery in NOD.Cg-Leah M Zadrozny, Lauren R Brinster, Barry A Rosenzweig, et al.
BMC Biotechnology|September 15, 2007
Characterization of the effect of sample quality on high density oligonucleotide microarray data using progressively degraded rat liver RNAKarol L Thompson, P Scott Pine, Barry A Rosenzweig, et al.
Kidney International|December 15, 2010
Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in ratsRodney L Rouse, Jun Zhang, Sharron R Stewart, et al.
Toxicology Letters|July 26, 2012
Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in ratsKarol L Thompson, Jun Zhang, Sharron Stewart, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 30, 2003
Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent componentsKarol L Thompson, Barry A Rosenzweig, James L Weaver, et al.
Disease Markers|April 26, 2016
The Effect of Oseltamivir on the Disease Progression of Lethal Influenza A Virus Infection: Plasma Cytokine and miRNA Responses in a Mouse ModelAshok K Chockalingam, Salaheldin Hamed, David G Goodwin, et al.
Environmental Health Perspectives|March 23, 2004
Dye bias correction in dual-labeled cDNA microarray gene expression measurementsBarry A Rosenzweig, P Scott Pine, Olen E Domon, et al.
International Journal of Toxicology|January 24, 2012
Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the ratKarol L Thompson, Kylie Haskins, Barry A Rosenzweig, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2009
Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in ratsKarol L Thompson, Barry A Rosenzweig, Jun Zhang, et al.
Pageof 2